Synthetic peptide derived from the C-terminal domain of human NAPRT1.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||Use at an assay dependent concentration.
||1/200 - 1/2000. Predicted molecular weight: 57 kDa.
Catalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). Essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells.
Cofactor biosynthesis; NAD(+) biosynthesis; nicotinate D-ribonucleotide from nicotinate: step 1/1.
Belongs to the NAPRTase family.
Cytoplasm > cytosol.
Information by UniProt
- FHA HIT interacting protein antibody
- FHA-HIT-interacting protein antibody
- FHIP antibody
Anti-NAPRT1 antibody (ab71566)参考文献
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"